D-1435-2012 Class II Terminated

Recalled by Dr. Reddy's Laboratories, Inc. — Bridgewater, NJ

FDA drug recall D-1435-2012 was initiated by Dr. Reddy's Laboratories, Inc. on Apr 9, 2012 and is designated Class II. Reason for recall: Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets The recall status is terminated (terminated Jan 24, 2013). Affected quantity: 1656 bottles.

Recall details

Product Type
Drugs
Report Date
Aug 8, 2012
Initiation Date
Apr 9, 2012
Termination Date
Jan 24, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1656 bottles

Product description

Dr. Reddy's Ciprofloxacin Tablets, USP 500 mg*, 500 Tablets, Rx only, Mfd. By: Dr. Reddy's Laboratories Limited, Bachepalli - 502 325 INDIA, NDC 55111-127-05

Reason for recall

Adulterated Presence of Foreign Tablets: Dr. Reddy's Laboratories has received complaints of mislabeled bottles of Amlodipine Besylate and Benazepril Hydrochloride Capsules and Ciprofloxacin Tablets

Distribution pattern

Nationwide and Puerto Rico

Code information

C201293 Exp Date 08/2013

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1435-2012
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1435-2012. Report a data issue: hello@regdatalab.com.